Endo Pharmaceuticals Inc. has agreed to pay $63 million to the state of Texas over the allegations that the company fueled the opioid epidemic devastating thousands of lives.
The settlement resolves two cases brought against the Endo subsidiaries that were consolidated in litigation in Texas state court. The company's main focus is to make a global opioid settlement or to provide alternative strategies if it fails to attain global deal.
The spokesperson for Endo said that the settlement does not include the company's admission of wrongdoing or liability in the lawsuit. Attorney General Ken Paxton explained that precise results from the investigation in the lawsuit claimed that the manufacturers are liable to the settlement as they fueled the opioid crisis in the state by using deceptive marketing strategies that resulted in disrupting the lives of victims and families. The settlement would help the state to heal from the devastating opioid crisis.
Earlier, a Tennessee state judge in April found that Endo was liable for holding back documents to get the opioid trial in their favor. The judge even held the law defendants' law firm responsible for making false claims.
In a similar lawsuit in New York state, Endo agreed on a $50 million settlement with the state. As per the settlement, New York state will get $22.3 million and the Long Island counties of Nassau and Suffolk will receive $27.7 million.
Endo even reached a $7.5 million deal with the Louisiana attorney general to resolve opioid claims throughout the state.
